Novartis AG (NOVN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Novartis AG (NOVN)
Company Performance

Current Price

as of Oct 16, 2024

$116.91

P/E Ratio

14.36

Market Cap

$230.79B

Description

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Metrics

Overview

  • HQBasel, BS
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerNOVN
  • Price$116.91023+0.17%

Trading Information

  • Market Cap$230.79B
  • Float89.22%
  • Average Daily Volume (1m)2,790,499
  • Average Daily Volume (3m)2,827,766
  • EPS$7.02

Company

  • Revenue$42.20B
  • Rev Growth (1yr)-7.58%
  • Net Income$2.94B
  • Gross Margin74.29%
  • EBITDA Margin40.68%
  • EBITDA$4.60B
  • EV$215.38B
  • EV/Revenue5.10
  • P/E14.36
  • P/S4.89
  • P/B5.44
Documents
Factset Street Account
Wikipedia